{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:11:08Z","timestamp":1789002668484,"version":"build-2803163510"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aim of these revised recommendations for the general management of Kawasaki disease is to encourage its prompter recognition and warrant the most appropriate therapy, based on ascertained scientific data, raising awareness of the complications related to misdiagnosis or delayed treatment. A set of 20 synthetic operative statements is herein provided, including the definition of Kawasaki disease, its protean presentations, clinical course and seminal treatment modalities of all disease phases. The application of these recommendations should improve prognosis of Kawasaki disease and prevent the progression to permanent vascular abnormalities, thereby diminishing morbidity and mortality.<\/jats:p>","DOI":"10.1186\/s13052-021-00962-4","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T07:06:05Z","timestamp":1611558365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease"],"prefix":"10.1186","volume":"47","author":[{"given":"Alessandra","family":"Marchesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Tarissi de Jacobis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rimini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cattalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Zorzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Dellepiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Salice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Secinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Taddio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"El Hachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cortis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corsello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"962_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13052-018-0536-3","volume":"44","author":"A Marchesi","year":"2018","unstructured":"Marchesi A, Tarissi De Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, et al. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr. 2018;44:102.","journal-title":"Ital J Pediatr"},{"key":"962_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13052-018-0529-2","volume":"44","author":"A Marchesi","year":"2018","unstructured":"Marchesi A, Tarissi De Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, et al. Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks. Ital J Pediatr. 2018;44:103.","journal-title":"Ital J Pediatr"},{"key":"962_CR3","first-page":"178","volume":"16","author":"T Kawasaki","year":"1967","unstructured":"Kawasaki T. Acute febrile mucocutaneus syndrome with lymphoid involvement with specific desquamation of the finger and toes in children. Arerugi. 1967;16:178\u2013222.","journal-title":"Arerugi."},{"key":"962_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/jpc.12172","volume":"49","author":"D Yim","year":"2013","unstructured":"Yim D, Curtis N, Cheung M, Burgner D. Update on Kawasaki disease: epidemiology, aetiology and pathogenesis. J Paediatr Child Health. 2013;49:704\u20138.","journal-title":"J Paediatr Child Health"},{"key":"962_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fped.2018.00374","volume":"6","author":"AH Rowley","year":"2018","unstructured":"Rowley AH, Shulman ST. The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr. 2018;6:374.","journal-title":"Front Pediatr"},{"key":"962_CR6","doi-asserted-by":"publisher","unstructured":"De Rose DU, Coppola M, Gallini F, Maggio L, Vento G, Rigante D. Overview of the rarest causes of fever in newborns: handy hints for the neonatologist. J Perinatol. 2020. Epub ahead of print. https:\/\/doi.org\/10.1038\/s41372-020-0744-8.","DOI":"10.1038\/s41372-020-0744-8"},{"key":"962_CR7","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2020.039","volume":"12","author":"D Rigante","year":"2020","unstructured":"Rigante D. Kawasaki disease as the immune-mediated echo of a viral infection. Mediterr J Hematol Infect Dis. 2020;12:e2020039.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"962_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1546-0096-9-17","volume":"9","author":"F Falcini","year":"2011","unstructured":"Falcini F, Capannini S, Rigante D. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr Rheumatol. 2011;9:17.","journal-title":"Pediatr Rheumatol"},{"key":"962_CR9","first-page":"1708","volume":"114","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management in Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young. Am Heart Assoc Pediatrics. 2004;114:1708\u201333.","journal-title":"Am Heart Assoc Pediatrics"},{"key":"962_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S1568-9972(03)00032-6","volume":"2","author":"R Cimaz","year":"2003","unstructured":"Cimaz R, Falcini F. An update on Kawasaki disease. Autoimmun Rev. 2003;2:258\u201363.","journal-title":"Autoimmun Rev"},{"key":"962_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11936-007-0008-3","volume":"9","author":"JW Newburger","year":"2007","unstructured":"Newburger JW, Fulton DR. Kawasaki Disease. Curr Treat Options Cardiovasc Med. 2007;9:148\u201358.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"962_CR12","first-page":"301","volume":"11","author":"G De Rosa","year":"2007","unstructured":"De Rosa G, Pardeo M, Rigante D. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications. Eur Rev Med Pharmacol Sci. 2007;11:301\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"962_CR13","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease, a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927\u201399.","journal-title":"Circulation."},{"key":"962_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jebm.12377","volume":"13","author":"D Rigante","year":"2020","unstructured":"Rigante D. When, how, and why do fevers hold children hostage? J Evid Based Med. 2020;13:85\u20138.","journal-title":"J Evid Based Med"},{"key":"962_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3345\/kjp.2012.55.3.83","volume":"55","author":"JJ Yu","year":"2012","unstructured":"Yu JJ. Diagnosis of incomplete Kawasaki disease. Korean J Pediatr. 2012;55:83\u20137.","journal-title":"Korean J Pediatr"},{"key":"962_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.inf.0000202067.50975.90","volume":"25","author":"FY Chang","year":"2006","unstructured":"Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J. 2006;25:241\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"962_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.berh.2009.08.010","volume":"23","author":"R Cimaz","year":"2009","unstructured":"Cimaz R, Sundel R. Atypical and incomplete Kawasaki disease. Best Pract Res Clin Rheumatol. 2009;23:689\u201397.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"962_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2188\/jea.JE20110126","volume":"22","author":"Y Nakamura","year":"2012","unstructured":"Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nation-wide survey. J Epidemiol. 2012;22:216\u201321.","journal-title":"J Epidemiol"},{"key":"962_CR19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/1744666X.2019.1659726","volume":"15","author":"AK Jindal","year":"2019","unstructured":"Jindal AK, Pilania RK, Prithvi A, Guleria S, Singh S. Kawasaki disease: characteristics, diagnosis, and unusual presentations. Expert Rev Clin Immunol. 2019;15:1089\u2013104.","journal-title":"Expert Rev Clin Immunol"},{"key":"962_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.bor.0000197998.50450.f6","volume":"18","author":"F Falcini","year":"2006","unstructured":"Falcini F. Kawasaki disease. Curr Opin Rheumatol. 2006;18:33\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"962_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24953\/turkjped.2020.01.001","volume":"62","author":"S T\u00fcrku\u00e7ar","year":"2020","unstructured":"T\u00fcrku\u00e7ar S, Y\u0131ld\u0131z K, Acar\u0131 C, Dundar HA, K\u0131r M, \u00dcnsal E. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. Turk J Pediatr. 2020;62:1\u20139.","journal-title":"Turk J Pediatr"},{"key":"962_CR22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00296-009-1337-1","volume":"30","author":"D Rigante","year":"2010","unstructured":"Rigante D, Valentini P, Rizzo D, Leo A, De Rosa G, Onesimo R, et al. Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int. 2010;30:841\u20136.","journal-title":"Rheumatol Int"},{"key":"962_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.gendis.2019.09.003","volume":"7","author":"K Arora","year":"2019","unstructured":"Arora K, Guleria S, Jindal AK, Rawat A, Singh S. Platelets in Kawasaki disease: is this only a numbers game or something beyond? Genes Dis. 2019;7:62\u20136.","journal-title":"Genes Dis"},{"key":"962_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","volume":"2","author":"K Furusho","year":"1984","unstructured":"Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984;2:1055\u20138.","journal-title":"Lancet."},{"key":"962_CR25","volume":"4","author":"RM Oates-Whitehead","year":"2003","unstructured":"Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2003;4:CD004000.","journal-title":"Cochrane Database Syst Rev"},{"key":"962_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jpeds.2003.12.033","volume":"144","author":"H Muta","year":"2004","unstructured":"Muta H, Ishii M, Egami K, Furui J, Sugahara Y, Akagi T, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr. 2004;144:496\u20139.","journal-title":"J Pediatr"},{"key":"962_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/INF.0b013e31827ad7c7","volume":"32","author":"I Shamim","year":"2013","unstructured":"Shamim I. Diagnosis and treatment of suspected Kawasaki disease before the fifth day of illness. Ped Inf Dis J. 2013;32:424.","journal-title":"Ped Inf Dis J"},{"key":"962_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/archdischild-2012-302841","volume":"99","author":"D Eleftheriou","year":"2013","unstructured":"Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA. Management of Kawasaki disease. Arch Dis Child. 2013;99:74\u201383.","journal-title":"Arch Dis Child"},{"key":"962_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217274","volume":"14","author":"X Zheng","year":"2019","unstructured":"Zheng X, Yue P, Liu L, Tang C, Ma F, Zhang Y, et al. Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis. PLoS One. 2019;14:e0217274.","journal-title":"PLoS One"},{"key":"962_CR30","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/rheumatology\/keaa050","volume":"59","author":"X Jia","year":"2020","unstructured":"Jia X, Du X, Bie S, Li X, Bao Y, Jiang M. What dose of aspirin should be used in the initial treatment of Kawasaki disease? A meta-analysis. Rheumatology (Oxford). 2020;59:1826\u201333.","journal-title":"Rheumatology (Oxford)"},{"key":"962_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2165\/00148581-200709030-00009","volume":"9","author":"DA Fitzgerald","year":"2007","unstructured":"Fitzgerald DA. Aspirin and Reye syndrome. Paediatr Drugs. 2007;9:205\u20136.","journal-title":"Paediatr Drugs"},{"key":"962_CR32","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00431-013-2101-9","volume":"172","author":"HM Yang","year":"2013","unstructured":"Yang HM, Du ZD, Fu PP. Clinical features of recurrent Kawasaki disease and its risk factors. Eur J Pediatr. 2013;172:1641\u20137.","journal-title":"Eur J Pediatr"},{"key":"962_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/1744666X.2017.1280396","volume":"13","author":"D Rigante","year":"2017","unstructured":"Rigante D. A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner. Expert Rev Clin Immunol. 2017;13:571\u201397.","journal-title":"Expert Rev Clin Immunol"},{"key":"962_CR34","doi-asserted-by":"publisher","first-page":"485103","DOI":"10.1155\/2013\/485103","volume":"2013","author":"D Rigante","year":"2013","unstructured":"Rigante D, Frediani B, Galeazzi M, Cantarini L. From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases. Biomed Res Int. 2013;2013:485103.","journal-title":"Biomed Res Int"},{"key":"962_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jebm.12406","volume":"13","author":"D Rigante","year":"2020","unstructured":"Rigante D. Phenotype variability of autoinflammatory disorders in the pediatric patient: a pictorial overview. J Evid Based Med. 2020;13:227\u201345.","journal-title":"J Evid Based Med."},{"key":"962_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJM198608073150601","volume":"315","author":"JW Newburger","year":"1986","unstructured":"Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341\u20137.","journal-title":"N Engl J Med"},{"key":"962_CR37","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1038\/s41598-020-59972-7","volume":"10","author":"M Piram","year":"2020","unstructured":"Piram M, Darce Bello M, Tellier S, Di Filippo S, Boralevi F, Madhi F, et al. Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease. Sci Rep. 2020;10:3125.","journal-title":"Sci Rep"},{"key":"962_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrrheum.2015.54","volume":"11","author":"ST Shulman","year":"2015","unstructured":"Shulman ST, Rowley AH. Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol. 2015;11:475\u201382.","journal-title":"Nat Rev Rheumatol"},{"key":"962_CR39","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","volume":"158","author":"LA Sleeper","year":"2011","unstructured":"Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158:831\u20135.","journal-title":"J Pediatr"},{"key":"962_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/ijms17030278","volume":"17","author":"D Rigante","year":"2016","unstructured":"Rigante D, Andreozzi L, Fastiggi M, Bracci B, Natale MF, Esposito S. Critical overview of the risk scoring systems to predict non-responsiveness to intravenous immunoglobulin in Kawasaki syndrome. Int J Mol Sci. 2016;17:278.","journal-title":"Int J Mol Sci"},{"key":"962_CR41","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","volume":"17","author":"JC Burns","year":"1998","unstructured":"Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki syndrome study group. Pediatr Infect Dis J. 1998;17:1144\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"962_CR42","first-page":"337","volume":"10","author":"D Rigante","year":"2006","unstructured":"Rigante D. Clinical overview of vasculitic syndromes in the pediatric age. Eur Rev Med Pharmacol Sci. 2006;10:337\u201345.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"962_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJMoa061235","volume":"356","author":"JW Newburger","year":"2007","unstructured":"Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007;356:663\u201375.","journal-title":"N Engl J Med"},{"key":"962_CR44","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1542\/peds.2011-0148","volume":"129","author":"S Ogata","year":"2012","unstructured":"Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. Pediatrics. 2012;129:e17\u201323.","journal-title":"Pediatrics."},{"key":"962_CR45","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised open-label blinded-endpoints trial. Lancet. 2012;379:1613\u201320.","journal-title":"Lancet."},{"key":"962_CR46","doi-asserted-by":"publisher","first-page":"6294","DOI":"10.4049\/jimmunol.176.10.6294","volume":"176","author":"JS Hii-Yuen","year":"2006","unstructured":"Hii-Yuen JS, Duong TT, Yeung RSM. TNF-\u03b1 is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol. 2006;176:6294\u2013301.","journal-title":"J Immunol"},{"key":"962_CR47","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/S0140-6736(89)91910-7","volume":"2","author":"DY Leung","year":"1989","unstructured":"Leung DY, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet. 1989;2:1298\u2013302.","journal-title":"Lancet."},{"key":"962_CR48","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","volume":"153","author":"JC Burns","year":"2008","unstructured":"Burns JC, Best BM, Mejias A, Mahony L, Fixler DE, Jafri HS, et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2008;153:833\u20138.","journal-title":"J Pediatr"},{"key":"962_CR49","doi-asserted-by":"publisher","unstructured":"Ferrara G, Giani T, Caparello MC, Farella C, Gamalero L, Cimaz R. Anakinra for treatment-resistant Kawasaki disease: evidence from a literature review. Paediatr Drugs. 2020;3. Epub ahead of print. https:\/\/doi.org\/10.1007\/s40272-020-00421-3.","DOI":"10.1007\/s40272-020-00421-3"},{"key":"962_CR50","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/art.39975","volume":"69","author":"JC Burns","year":"2017","unstructured":"Burns JC, Kon\u00e9-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M. Found in translation: international initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki disease. Arthritis Rheumatol. 2017;69:268\u201376.","journal-title":"Arthritis Rheumatol"},{"key":"962_CR51","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fphar.2016.00380","volume":"7","author":"A Vitale","year":"2016","unstructured":"Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, et al. A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study. Front Pharmacol. 2016;7:380.","journal-title":"Front Pharmacol"},{"key":"962_CR52","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0022-3476(98)70229-X","volume":"133","author":"A de Zorzi","year":"1998","unstructured":"de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998;133:254\u20138.","journal-title":"J Pediatr"},{"key":"962_CR53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/1756-185X.13216","volume":"21","author":"BW McCrindle","year":"2018","unstructured":"McCrindle BW, Cifra B. The role of echocardiography in Kawasaki disease. Int J Rheum Dis. 2018;21:50\u20135.","journal-title":"Int J Rheum Dis"},{"key":"962_CR54","first-page":"157","volume":"48","author":"JC Burns","year":"2001","unstructured":"Burns JC. Kawasaki disease. Adv Pediatr Infect Dis. 2001;48:157\u201377.","journal-title":"Adv Pediatr Infect Dis"},{"key":"962_CR55","first-page":"53","volume":"10","author":"A Stabile","year":"2006","unstructured":"Stabile A, Bertoni B, Ansuini V, La Torraca I, Sall\u00ec A, Rigante D. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. Eur Rev Med Pharmacol Sci. 2006;10:53\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"962_CR56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.semarthrit.2014.07.007","volume":"44","author":"W Wang","year":"2015","unstructured":"Wang W, Gong F, Zhu W, Fu S, Zhang Q. Macrophage activation syndrome in Kawasaki disease: more common than we thought? Semin Arthritis Rheum. 2015;44:405\u201310.","journal-title":"Semin Arthritis Rheum"},{"key":"962_CR57","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1542\/peds.2008-1871","volume":"123","author":"JT Kanegaye","year":"2009","unstructured":"Kanegaye JT, Wilder MS, Molkara D, Frazer JR, Pancheri J, Tremoulet AH, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009;123:e783\u20139.","journal-title":"Pediatrics."},{"key":"962_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/1756-185X.13207","volume":"21","author":"K Takahashi","year":"2018","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y. Histopathological aspects of cardiovascular lesions in Kawasaki disease. Int J Rheum Dis. 2018;21:31\u20135.","journal-title":"Int J Rheum Dis"},{"key":"962_CR59","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1542\/peds.2013-1638","volume":"133","author":"TJ Holve","year":"2014","unstructured":"Holve TJ, Patel A, Chau Q, Marks AR, Meadows A, Zaroff JG. Long-term cardiovascular outcomes in survivors of Kawasaki disease. Pediatrics. 2014;133:e305\u201311.","journal-title":"Pediatrics."},{"key":"962_CR60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0022-3476(82)80639-2","volume":"100","author":"Y Sasaguri","year":"1982","unstructured":"Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: a pathological study. J Pediatr. 1982;100:225\u201331.","journal-title":"J Pediatr"},{"key":"962_CR61","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00431-011-1630-3","volume":"171","author":"D Sudo","year":"2012","unstructured":"Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, Sonobe T, Nakamura Y. Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr. 2012;171:651\u20136.","journal-title":"Eur J Pediatr"},{"key":"962_CR62","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3400\/avd.sasvp01003","volume":"3","author":"K Takahashi","year":"2010","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y, Hiruta N, Naoe S. Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis. 2010;3:173\u201381.","journal-title":"Ann Vasc Dis"},{"key":"962_CR63","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIRCULATIONAHA.107.690875","volume":"116","author":"BW McCrindle","year":"2007","unstructured":"McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, et al. Pediatric Heart Network Investigators. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007;116:174\u20139.","journal-title":"Circulation."},{"key":"962_CR64","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1258\/ar.2012.120484","volume":"54","author":"JW Kim","year":"2013","unstructured":"Kim JW, Goo HW. Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography. Acta Radiol. 2013;54:156\u201363.","journal-title":"Acta Radiol"},{"key":"962_CR65","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1540-8175.2011.01486.x","volume":"28","author":"Y Yu","year":"2011","unstructured":"Yu Y, Sun K, Wang R, Li Y, Xue H, Yu L, et al. Comparison study of echocardiography and dual-source CT in diagnosis of coronary artery aneurysm due to Kawasaki disease: coronary artery disease. Echocardiography. 2011;28:1025\u201334.","journal-title":"Echocardiography."},{"key":"962_CR66","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/CIRCIMAGING.111.965996","volume":"4","author":"CE Tacke","year":"2011","unstructured":"Tacke CE, Kuipers IM, Groenink M, Spijkerboer AM, Kuijpers TW. Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imaging. 2011;4:712\u201320.","journal-title":"Circ Cardiovasc Imaging"},{"key":"962_CR67","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1161\/01.cir.0000436140.77832.7a","volume":"128","author":"TM Giglia","year":"2013","unstructured":"Giglia TM, Massicotte MP, Tweddell JS, Barst RJ, Bauman M, Erickson CC, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease - a scientific statement from the American Heart Association. Circulation. 2013;128:2622\u2013703.","journal-title":"Circulation."},{"key":"962_CR68","doi-asserted-by":"crossref","unstructured":"Hanke CA, Stiller B, Nakamura L, Grohmann J, Zieger B. Prophylactic use of clopidogrel in paediatric cardiac patients. Klin Padiatr. 2012;224:166-9.","DOI":"10.1055\/s-0032-1306345"},{"key":"962_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00246-010-9836-0","volume":"32","author":"C Gentilomo","year":"2011","unstructured":"Gentilomo C, Huang YS, Raffini L. Significant increase in clopidogrel use across U.S. children's hospitals. Pediatr Cardiol. 2011;32:167\u201375.","journal-title":"Pediatr Cardiol"},{"key":"962_CR70","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000366052","volume":"129","author":"M Levin","year":"2014","unstructured":"Levin M, Burns JC, Gordon JB. Warfarin plus aspirin or aspirin alone for patients with giant coronary artery aneurysms secondary to Kawasaki disease? Cardiology. 2014;129:174\u20137.","journal-title":"Cardiology."},{"key":"962_CR71","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","volume":"164","author":"JD Douketis","year":"2004","unstructured":"Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med. 2004;164:1319\u201326.","journal-title":"Arch Intern Med"},{"key":"962_CR72","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/pbc.23011","volume":"57","author":"G Young","year":"2011","unstructured":"Young G, Yee DL, O'Brien SH, Khanna R, Barbour A, Nugent DJ. FondaKIDS: a prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age. Pediatr Blood Cancer. 2011;57:1049\u201354.","journal-title":"Pediatr Blood Cancer"},{"key":"962_CR73","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.acvd.2019.10.008","volume":"113","author":"V Pham","year":"2020","unstructured":"Pham V, Hemptinne Q, Grinda JM, Duboc D, Varenne O, Picard F. Giant coronary aneurysms, from diagnosis to treatment: a literature review. Arch Cardiovasc Dis. 2020;113:59\u201369.","journal-title":"Arch Cardiovasc Dis"},{"key":"962_CR74","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fped.2017.00260","volume":"5","author":"C Tarango","year":"2017","unstructured":"Tarango C, Manco-Johnson MJ. Pediatric thrombolysis: a practical approach. Front Pediatr. 2017;5:260.","journal-title":"Front Pediatr"},{"key":"962_CR75","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1089253215573328","volume":"19","author":"PN Jone","year":"2015","unstructured":"Jone PN, Tapia D, Davidson J, Fagan TE, Browne L, Ing RJ, et al. Successful treatment of myocardial infarction in an infant with Kawasaki disease. Semin Cardiothorac Vasc Anesth. 2015;19:255\u20139.","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"962_CR76","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijcard.2016.06.062","volume":"220","author":"E Bachlava","year":"2016","unstructured":"Bachlava E, Loukopoulou S, Karanasios E, Chrousos G, Michos A. Management of coronary artery aneurysms using abciximab in children with Kawasaki disease. Int J Cardiol. 2016;220:65\u20139.","journal-title":"Int J Cardiol"},{"key":"962_CR77","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4070\/kcj.2011.41.2.53","volume":"41","author":"T Akagi","year":"2011","unstructured":"Akagi T. Catheter interventions for Kawasaki disease: current concepts and future directions. Korean Circ J. 2011;41:53\u20137.","journal-title":"Korean Circ J"},{"key":"962_CR78","doi-asserted-by":"crossref","unstructured":"Agrawal H, Qureshi AM. Cardiac catheterization in assessment and treatment of Kawasaki disease in children and adolescents. Children (Basel). 2019;6:32.","DOI":"10.3390\/children6020032"},{"key":"962_CR79","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1161\/01.CIR.93.9.1709","volume":"93","author":"T Ino","year":"1996","unstructured":"Ino T, Akimoto K, Ohkubo M, Nishimoto K, Yabuta K, Takaya J, et al. Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. Circulation. 1996;93:1709\u201315.","journal-title":"Circulation."},{"key":"962_CR80","doi-asserted-by":"publisher","first-page":"371","DOI":"10.7182\/pit2013252","volume":"23","author":"SM Mirhosseini","year":"2013","unstructured":"Mirhosseini SM, Asadollahi S, Fakhri M. Orthotopic heart transplant for treatment-resistant cardiomyopathy in Kawasaki syndrome: report of a successful case. Prog Transplant. 2013;23:371\u20133.","journal-title":"Prog Transplant"},{"key":"962_CR81","doi-asserted-by":"crossref","unstructured":"de Magalh\u00e3es MRC, Coutinho de Almeida F, Gandolfi L, Pratesi R, Ribeiro de MAN, Selleski N, et al. Clinical manifestations of Kawasaki disease at different age spectrum: a ten-year study. Medicina (Kaunas). 2020;56:145.","DOI":"10.3390\/medicina56040145"},{"key":"962_CR82","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00246-001-9070-x","volume":"23","author":"IY Kahwaji","year":"2002","unstructured":"Kahwaji IY, Connuck DM, Tafari N, Dahdah NS. A national survey on the pediatric cardiologist's clinical approach for patients with Kawasaki disease. Pediatr Cardiol. 2002;23:639\u201346.","journal-title":"Pediatr Cardiol"},{"key":"962_CR83","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1586\/14760584.2016.1128329","volume":"15","author":"S Esposito","year":"2016","unstructured":"Esposito S, Bianchini S, Dellepiane RM, Principi N. Vaccines and Kawasaki disease. Expert Rev Vaccines. 2016;15:417\u201324.","journal-title":"Expert Rev Vaccines"},{"key":"962_CR84","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","volume":"183","author":"CR Consiglio","year":"2020","unstructured":"Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183:968\u201381 e7.","journal-title":"Cell"},{"key":"962_CR85","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jpeds.2020.04.052","volume":"222","author":"AS Harahsheh","year":"2020","unstructured":"Harahsheh AS, Dahdah N, Newburger JW, Portman MA, Piram M, Tulloh R, et al. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic. J Pediatr. 2020;222:261\u20132.","journal-title":"J Pediatr"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-00962-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-021-00962-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-00962-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T10:04:29Z","timestamp":1674900269000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-021-00962-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["962"],"URL":"https:\/\/doi.org\/10.1186\/s13052-021-00962-4","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"16 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}